Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Total article views   HTML views PDF downloads Totals
9,689 Dovepress* 7,833+ 1,935 9,768
PubMed Central* 1,856 413 2,269
Totals 9,689 2,348 12,037
*Since 25 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar